Mavriopoulou E[au] - Search Results

Year	Number of Results
2013	1
2015	2
2018	2
2019	2
2020	2
2021	1
2024	1

1

FAPI-74 PET/CT Using Either ¹⁸F-AlF or Cold-Kit ⁶⁸Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients.

Giesel FL, Adeberg S, Syed M, Lindner T, Jiménez-Franco LD, Mavriopoulou E, Staudinger F, Tonndorf-Martini E, Regnery S, Rieken S, El Shafie R, Röhrich M, Flechsig P, Kluge A, Altmann A, Debus J, Haberkorn U, Kratochwil C. Giesel FL, et al. Among authors: mavriopoulou e. J Nucl Med. 2021 Feb;62(2):201-207. doi: 10.2967/jnumed.120.245084. Epub 2020 Jun 26. J Nucl Med. 2021. PMID: 32591493 Free PMC article.

2

Dosimetry Estimate and Initial Clinical Experience with ⁹⁰Y-PSMA-617.

Rathke H, Flechsig P, Mier W, Bronzel M, Mavriopoulou E, Hohenfellner M, Giesel FL, Haberkorn U, Kratochwil C. Rathke H, et al. Among authors: mavriopoulou e. J Nucl Med. 2019 Jun;60(6):806-811. doi: 10.2967/jnumed.118.218917. Epub 2018 Nov 2. J Nucl Med. 2019. PMID: 30389816 Free article.

3

Comparison of 68Ga-DOTATOC biodistribution in patients with and without spleenectomy.

Kratochwil C, Mavriopoulou E, Rath D, Afshar-Oromieh A, Apostolopoulos D, Haufe S, Mier W, Haberkorn U, Giesel FL. Kratochwil C, et al. Among authors: mavriopoulou e. Q J Nucl Med Mol Imaging. 2015 Mar;59(1):116-20. Epub 2013 Dec 17. Q J Nucl Med Mol Imaging. 2015. PMID: 24382404

4

Response Prediction of ¹⁷⁷Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase.

Rathke H, Holland-Letz T, Mier W, Flechsig P, Mavriopoulou E, Röhrich M, Kopka K, Hohenfellner M, Giesel FL, Haberkorn U, Kratochwil C. Rathke H, et al. Among authors: mavriopoulou e. J Nucl Med. 2020 May;61(5):689-695. doi: 10.2967/jnumed.119.231431. Epub 2019 Oct 25. J Nucl Med. 2020. PMID: 31653712 Free article.

5

Diagnostic Potential of Supplemental Static and Dynamic ⁶⁸Ga-FAPI-46 PET for Primary ¹⁸F-FDG-Negative Pulmonary Lesions.

Röhrich M, Daum J, Gutjahr E, Spektor AM, Glatting FM, Sahin YA, Buchholz HG, Hoppner J, Schroeter C, Mavriopoulou E, Schlamp K, Grott M, Eichhorn F, Heußel CP, Kauczor HU, Kreuter M, Giesel F, Schreckenberger M, Winter H, Haberkorn U. Röhrich M, et al. Among authors: mavriopoulou e. J Nucl Med. 2024 Apr 11:jnumed.123.267103. doi: 10.2967/jnumed.123.267103. Online ahead of print. J Nucl Med. 2024. PMID: 38604763

6

SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors.

Kratochwil C, Stefanova M, Mavriopoulou E, Holland-Letz T, Dimitrakopoulou-Strauss A, Afshar-Oromieh A, Mier W, Haberkorn U, Giesel FL. Kratochwil C, et al. Among authors: mavriopoulou e. Mol Imaging Biol. 2015 Jun;17(3):313-8. doi: 10.1007/s11307-014-0795-3. Mol Imaging Biol. 2015. PMID: 25319765

7

Whole body bone SPET/CT can successfully replace the conventional bone scan in breast cancer patients. A prospective study of 257 patients.

Mavriopoulou E, Zampakis P, Smpiliri E, Spyridonidis T, Rapti E, Haberkorn U, Makatsoris T, Apostolopoulos DJ. Mavriopoulou E, et al. Hell J Nucl Med. 2018 May-Aug;21(2):125-133. Hell J Nucl Med. 2018. PMID: 30089314 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year